Jan 31 |
InspireMD Receives CE Mark Recertification Under EU’s New Medical Device Regulation (MDR) Regulatory Framework
|
Jan 23 |
We're Hopeful That InspireMD (NASDAQ:NSPR) Will Use Its Cash Wisely
|
Jan 3 |
InspireMD Announces Appointment of Medical Technology Executive Pete Ligotti as Executive Vice President and General Manager of North America
|
Dec 20 |
InspireMD Announces Issuance of Key U.S. Patent Covering Its SwitchGuard™ Neuroprotection System
|
Dec 6 |
InspireMD's Gary Roubin Acquires 13% More Stock
|
Dec 4 |
InspireMD says Roubin buys 50K shares in co
|
Nov 27 |
InspireMD Announces Strategic Agreement with Jacobs Institute to Execute Early Feasibility Study of CGuard EPS for the Treatment of Acute Stroke Patients with Tandem Lesions
|
Nov 7 |
InspireMD, Inc. (NASDAQ:NSPR) Q3 2023 Earnings Call Transcript
|
Nov 6 |
InspireMD Inc. (NSPR) Q3 2023 Earnings Call Transcript
|
Nov 6 |
InspireMD Inc (NSPR) Reports Q3 2023 Financial Results: CGuard EPS Revenue Increases by 9% ...
|